Results 141 to 150 of about 79,740 (296)

Advancing antihypertensive drug development

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 15, Page 3389-3410, August 2025.
Hypertension affects more than a billion individuals worldwide and remains a major cause of cardiovascular morbidity and mortality. Despite advances in therapies, optimal blood pressure control remains elusive for many patients because of treatment resistance, adverse effects, and adherence challenges.
Fay Pu   +5 more
wiley   +1 more source

Water diuresis [PDF]

open access: yesThe Journal of Physiology, 1930
openaire   +2 more sources

Patient Participation in Urine Specific Gravity Screening for Arginine Vasopressin Deficiency in an Inpatient Neurosurgical Clinic

open access: yesClinical Endocrinology, Volume 103, Issue 2, Page 201-208, August 2025.
ABSTRACT Objective Detecting hypotonic urine (specific gravity < 1005 g/L) is crucial for the early identification of arginine vasopressin deficiency (AVP‐deficiency), a common complication after pituitary surgery. This study aimed to evaluate the agreement between urine specific gravity measurements taken by patients using urine test strips and those ...
Jeanne‐Marie Nollen   +7 more
wiley   +1 more source

Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 8, Page 4415-4426, August 2025.
Abstract Aims We assessed the effects of dapagliflozin on natriuresis and blood pressure in patients with type 2 diabetes and chronic kidney disease (CKD) and evaluated the consistency of these effects across patients with type 2 diabetes without CKD and CKD without type 2 diabetes.
Jelle M. Beernink   +16 more
wiley   +1 more source

Regulation of atrial natriuretic factor release in man: Effect of water immersion [PDF]

open access: yes, 1986
Arendt, Rainer M.   +6 more
core   +1 more source

Effect of hydration schedules on dose‐limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 7, Page 1996-2007, July 2025.
Abstract Aims The aim of this study was to determine if head and neck squamous cell carcinoma (HNSCC) patients treated with cisplatin chemoradiotherapy and short hydration (SH) experience less dose‐limiting toxicity (DLT) and receive more cisplatin than those with medium hydration (MH) or long hydration (LH).
Anouk W. M. A. Schaeffers   +10 more
wiley   +1 more source

Persistent Renal Oxidative Stress Despite Mannitol Nephroprotection: The Impact of Social‐Single Prolonged Stress in Male and Female Rats Exposed to Cisplatin

open access: yesCell Biochemistry and Function, Volume 43, Issue 7, July 2025.
ABSTRACT Cisplatin (CIS) is a chemotherapeutic agent known for nephrotoxicity through oxidative stress. Cancer treatment is also associated with psychological stress. Repeated exposure to social‐single prolonged stress (social‐SPS) modulates long‐term renal oxidative damage and apoptosis in a sex‐dependent manner in rats treated with cisplatin (CIS ...
Juliano Ten Kathen Jung   +5 more
wiley   +1 more source

Physiologic responses to water immersion in man: A compendium of research [PDF]

open access: yes
A total of 221 reports published through December 1973 in the area of physiologic responses to water immersion in man were summarized. The author's abstract or summary was used whenever possible.
Dorchak, K. J.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy